3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Unknown
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Myeloid
1
Conditions
Carcinoma, Non-Small-Cell Lung
79
Nasopharyngeal Carcinoma
51
Uterine Cervical Neoplasms
44
Lung Neoplasms
38
Esophageal Neoplasms
32
Head and Neck Neoplasms
28
Esophageal Squamous Cell Carcinoma
28
Squamous Cell Carcinoma of Head and Neck
22
Stomach Neoplasms
20
Breast Neoplasms
16
Small Cell Lung Carcinoma
15
Recurrence
12
Neoplasm Metastasis
12
Nasopharyngeal Neoplasms
12
Carcinoma, Squamous Cell
10
Ovarian Neoplasms
9
Central Nervous System Neoplasms
9
Neuroblastoma
8
Lymphoma, Large B-Cell, Diffuse
8
Pancreatic Neoplasms
7
Lymphoma
7
Hypopharyngeal Neoplasms
7
Triple Negative Breast Neoplasms
6
Oropharyngeal Neoplasms
6
Neoplasms
6
Biliary Tract Neoplasms
6
Urinary Bladder Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Follicular
5
Interventions
pegaspargase
14
Etoposide
11
Dexamethasone
11
Gemcitabine
10
spartalizumab
6
Oxaliplatin
4
sintilimab
3
Radiotherapy
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Methotrexate
3
Asparaginase
3
tislelizumab
2
camrelizumab
2
Lenalidomide
2
Drug Therapy
2
Cyclophosphamide
2
Cisplatin
2
Busulfan
2
Azacitidine
2
toripalimab
1
tofacitinib
1
ruxolitinib
1
romidepsin
1
pembrolizumab
1
fludarabine phosphate
1
avelumab
1
apatinib
1
Thalidomide
1
Sensitivity and Specificity
1
Psychiatric Rehabilitation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Extranodal NK-T-Cell
×
Cisplatin
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled
NCT01501136
2015-07-17
CTTNKTL-I/II
Zhengzhou University
Phase 4
Unknown
200 enrolled